The genetic architecture of fibromyalgia across 2.5 million individuals
Multi-ancestry GWAS meta-analysis of fibromyalgia with 54K cases and 2.5M controls from 11 cohorts.
- GWAS
- 5
- Loci
- 26
- Build
- hg38
Preview. See paingenomics.org for genome-wide variant search.
From Kerrebijn et al. 2026, Nature Medicine
Genome-wide summary statistics for the fibromyalgia meta-analysis. The full-cohort, multi-ancestry result is the primary analysis. Also available are European-ancestry and sex-stratified GWAS.
All sumstats and polygenic risk scores from this study (Kerrebijn et al., 2026) are available on the Chronic Pain Genomics Consortium website and on Zenodo, including additional leave-each-cohort-out sumstats.
Polygenic risk scores
Full cohort
European and sex-stratified
Data sources
- All of Us9,913 cases and 382,496 controls. EUR, AFR, AMR.
- Estonian Biobank2,434 cases and 203,471 controls. EUR.
- FinnGen6,864 cases and 493,739 controls. EUR.
- Genes & Health1,148 cases and 42,626 controls. CSA.
- deCODE genetics12,256 cases and 304,129 controls. EUR.
- UK Biobank7,220 cases and 430,948 controls. EUR, AFR, CSA.
- Nashville Biosciences2,189 cases and 103,313 controls. EUR, AFR.
- Copenhagen Hospital Biobank4,911 cases and 367,699 controls. EUR.
- Intermountain Health2,904 cases and 89,898 controls. EUR.
- Michigan Genomics Initiative3,334 cases and 41,210 controls. EUR, AFR.
- Mass General Brigham Biobank1,456 cases and 49,597 controls. EUR.